Safety, efficacy and immune effects of venetoclax 400 mg daily in patients (pts) with relapsed chronic lymphocytic leukemia (CLL) Meeting Abstract
| Authors: | Anderson, M. A.; Roberts, A. W.; Seymour, J. F.; Gerecitano, J. F.; Kahl, B. S.; Kipps, T. J.; Pagel, J. M.; Puvvada, S. D.; Wierda, W. G.; Gressick, L.; Zhu, M.; Dunbar, M.; Chyla, B.; Verdugo, M.; Kim, S. Y.; Davids, M. S. |
| Abstract Title: | Safety, efficacy and immune effects of venetoclax 400 mg daily in patients (pts) with relapsed chronic lymphocytic leukemia (CLL) |
| Meeting Title: | 21st Congress of the European Hematology Association (EHA) |
| Journal Title: | Haematologica |
| Volume: | 101 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2016 Jun 9-12 |
| Meeting Location: | Copenhagen, Denmark |
| ISSN: | 0390-6078 |
| Publisher: | Ferrata Storti Foundation |
| Date Published: | 2016-06-01 |
| Start Page: | 228 |
| Language: | English |
| ACCESSION: | WOS:000379484600499 |
| PROVIDER: | wos |
| PMCID: | PMC4894295 |
| Notes: | Meeting Abstract: P591 -- Source: Wos |
MSK Authors
-
153Gerecitano